Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma

by April K.S. Salama
Published 2013-01-01

Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma

by April K.S. Salama
Published 2013-06-01

A Review of Immune-Mediated Adverse Events in Melanoma

by Lucy Boyce Kennedy, April K. S. Salama
Published 2019-07-01

Updates in Therapy for Advanced Melanoma

by Bhavana P. Singh, April K. S. Salama
Published 2016-01-01

Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy

by Irena Tan, Michael Malinzak, April K. S. Salama
Published 2018-07-01

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis

by Norma E. Farrow, Megan C. Turner, April K. S. Salama, Georgia M. Beasley
Published 2020-05-01

Hazard-rate analysis and patterns of recurrence in early stage melanoma: moving towards a rationally designed surveillance strategy.

by April K S Salama, Nicole de Rosa, Randall P Scheri, Scott K Pruitt, James E Herndon, Jennifer Marcello, Douglas S Tyler, Amy P Abernethy
Published 2013-01-01

Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer

by Anushka Dikshit, Junqi Lu, Amy E. Ford, Simone Degan, Yingai J. Jin, Huiying Sun, Amanda Nichols, April K.S. Salama, Georgia Beasley, David Gooden, Jennifer Y. Zhang
Published 2021-09-01

Operative and peri‐operative considerations in the management of brain metastasis

by Eric W. Sankey, Vadim Tsvankin, Matthew M. Grabowski, Gautam Nayar, Kristen A. Batich, Aida Risman, Cosette D. Champion, April K. S. Salama, C. Rory Goodwin, Peter E. Fecci
Published 2019-11-01

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

by Nicholas C. DeVito, Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K.S. Salama, Georgia M. Beasley, Alisha Holtzhausen, Veronica Novotny-Diermayr, John H. Strickler, Brent A. Hanks
Published 2021-05-01